LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.76 | 17.25 | 11796 | 6047 | 1.9504 | 1.1645 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.74 | 17.25 | 12847 | 6109 | 2.1028 | 1.1835 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.74 | 17.25 | 2 | 6109 | 0.0003 | -0.2247 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 90.74 | 17.25 | 11895 | 6109 | 1.9469 | 1.1637 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.71 | 17.25 | 13024 | 6184 | 2.1060 | 1.1835 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 92.71 | 17.25 | 12084 | 6184 | 1.9540 | 1.1643 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 17.25 | 13232 | 6239 | 2.1208 | 1.1850 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 94.68 | 17.25 | 11746 | 6239 | 1.8826 | 1.1546 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.06 | 17.25 | 220 | 143 | 1.5362 | 1.3019 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 3.06 | 17.25 | 349 | 143 | 2.4369 | 1.6775 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.03 | 17.25 | 367 | 273 | 1.3426 | 1.1534 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 5.03 | 17.25 | 612 | 273 | 2.2388 | 1.4482 | MN20160310_N02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.01 | 17.25 | 678 | 389 | 1.7407 | 1.2624 | MN20160310_N02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | K13 |